Can sertraline cause a sensation of ear fullness or plugged ears?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Sertraline Cause Plugged Ears?

Sertraline can rarely cause ear fullness or a sensation of plugged ears, though this is not a commonly documented side effect in major guidelines or FDA labeling. The sensation is more likely related to discontinuation syndrome, underlying conditions that mimic ear fullness, or rare individual reactions rather than a direct pharmacological effect of the medication.

Evidence from FDA Labeling and Guidelines

The FDA-approved labeling for sertraline does not list ear fullness or plugged ears as a recognized adverse effect 1. The documented side effects focus on:

  • Gastrointestinal symptoms (nausea, diarrhea)
  • Central nervous system effects (dizziness, somnolence, tremor)
  • Sexual dysfunction
  • Bleeding risk
  • Serotonin syndrome

However, sertraline discontinuation syndrome does include dizziness, vertigo, and sensory disturbances 2, which patients may interpret as ear-related symptoms. This syndrome occurs with missed doses or abrupt discontinuation and is characterized by imbalance and sensory changes that could manifest as perceived ear fullness.

Clinical Context: When Ear Fullness Occurs

Direct Medication Effect (Rare)

One case report documented bilateral tinnitus developing after several weeks of sertraline 50 mg, which completely resolved after discontinuation 3. This suggests that in rare instances, sertraline may affect auditory processing through serotonergic modulation of cochlear input. The mechanism may involve:

  • Distribution of serotonin receptor subtypes within the auditory system
  • Reinforcement or desensitization of different receptor activities
  • Potential priming effects from concurrent medications (like aspirin in the reported case)

Discontinuation Syndrome

More commonly, ear-related symptoms occur during withdrawal rather than active treatment. Sertraline is specifically associated with discontinuation syndrome 2, which includes:

  • Dizziness and vertigo
  • Sensory disturbances and paresthesias
  • Imbalance

These symptoms can be perceived as ear fullness or plugged ears by patients.

Differential Diagnosis: What Else Could It Be?

When a patient on sertraline reports plugged ears, consider these more likely causes 4:

Primary culprits (94.7% of unexplained ear fullness cases):

  • Temporomandibular joint (TMJ) dysfunction - especially if pain accompanies the fullness
  • Intermittent Eustachian tube dysfunction (iETD) - more likely with isolated ear fullness
  • Migraine disorder - can present with aural fullness
  • Anxiety disorders - the very condition being treated may manifest as ear symptoms

Important note: Women are significantly more likely to present with ear fullness without objective abnormalities 4.

Clinical Approach

Immediate Assessment

  1. Verify medication adherence - Has the patient missed doses or recently changed dosing? This suggests discontinuation syndrome
  2. Check for objective findings:
    • Otomicroscopic examination
    • Audiometry (looking for sudden sensorineural hearing loss)
    • Tympanometry for middle ear function
  3. Assess timing: Did symptoms start within weeks of initiating sertraline (rare direct effect) or after dose changes/missed doses (discontinuation syndrome)?

If No Objective Abnormalities Found

Do not immediately attribute to sertraline. Instead, systematically evaluate:

  • TMJ dysfunction (jaw pain, clicking, limited opening)
  • Eustachian tube dysfunction (pressure changes with swallowing, popping)
  • Migraine features (headache history, photophobia, phonophobia)
  • Anxiety severity (may be undertreated)

Management Decision Tree

If discontinuation syndrome suspected:

  • Resume regular dosing immediately
  • Symptoms should resolve within 24-48 hours
  • If planning to discontinue sertraline, taper over 10-14 days 5

If rare direct sertraline effect suspected (persistent symptoms on stable dosing, no other cause found):

  • Consider trial discontinuation with slow taper
  • Symptoms should resolve completely within days to weeks after stopping 3
  • Switch to alternative antidepressant if needed (consider those with lower discontinuation syndrome risk like fluoxetine)

If underlying condition identified:

  • Treat the primary cause (TMJ therapy, nasal steroids for ETD, migraine prophylaxis)
  • Continue sertraline if effectively treating depression/anxiety
  • Only 5.3% of cases remain completely unexplained 4

Critical Pitfalls to Avoid

  1. Don't assume causation without temporal relationship - Ear fullness is extremely common and often unrelated to medications
  2. Don't abruptly stop sertraline - This can worsen symptoms through discontinuation syndrome and compromise psychiatric treatment
  3. Don't overlook serious causes - While rare, sudden hearing loss requires urgent evaluation 6
  4. Don't miss anxiety as the culprit - The underlying anxiety disorder may manifest as somatic symptoms including ear fullness

Bottom Line

Plugged ears are not a recognized common side effect of sertraline based on FDA labeling and major clinical guidelines. When this symptom occurs, it's most likely due to discontinuation syndrome (if dosing is irregular), the underlying anxiety/depression manifesting somatically, or concurrent conditions like TMJ dysfunction or Eustachian tube problems. True sertraline-induced ear symptoms are rare but documented in isolated case reports and should only be diagnosed after excluding other causes and observing resolution with medication discontinuation.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Making Recommendations for an Evaluation and Treatment Algorithm for Patients with Ear Fullness and No Objective Abnormalities.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2024

Guideline

clinical practice guideline: sudden hearing loss.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.